Chemistry in Medical Technology

Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimer's Disease

... loss. In addition, the company's proprietary chemistry is based on natural molecular scaffolds which ... functional responses and proprietary medicinal chemistry that ensures novel, high quality small-molecule ... to the toxic proteins. Cognition's proprietary chemistry platform converts natural products into low ...

New Bisphenol A Study Is of Very Limited Relevance to Human Health

... to Steven G. Hentges, Ph.D. of the American chemistry Council's (ACC) Polycarbonate/BPA Global Group. ... Retha R. Newbold of NIEHS. "The American chemistry Council (ACC) and its member companies have ... www.americanchemistry.com The American chemistry Council (ACC) represents the leading companies ...

Pharmatek's Highly-Potent and Cytotoxic (HP/C) Facility Positions It as Industry Leader in Development and Manufacturing of HP/C Compounds

... Laboratories, Inc. - a premier pharmaceutical chemistry development organization supporting the ... Pharmatek Laboratories Inc. is a pharmaceutical chemistry development company providing full-service pharmaceutical chemistry product development for the pharmaceutical ...

Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease

... 2002-2003. Dr. Bakshi has a Ph.D. in Bioorganic chemistry from the Center for Biochemical Technology, New Delhi, and a Master of Science in Organic chemistry and Bachelor of Science in chemistry from the University of Delhi, New Delhi. ...

deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders

... selective PDE4D modulator discovered by deCODE's chemistry group. First and second generation PDE4 ... ligands. Those structures allowed the deCODE chemistry team to identify a novel binding site for ... at http://www.decodeyou.com . About deCODE chemistry & biostructures deCODE chemistry, Inc. & deCODE ...

New Bisphenol A Study Has Limited Capability to Assess Human Health Effects

... stated Steven G. Hentges, Ph.D. of the American chemistry Council's Polycarbonate/BPA Global Group. "The ... http://www.americanchemistry.com The American chemistry Council (ACC) represents the leading ... research and product testing. The business of chemistry is a $664 billion enterprise and a key element of ...

Enanta Initiates Phase 1 Study on EDP-322, an Oral Antibiotic With Activity Against Hospital- and Community-Acquired MRSA

... chemical structures. Enanta has applied its chemistry approach to create a promising pipeline ... and development company that uses its novel chemistry approach and drug discovery capabilities to ... heart of Enanta is its commitment to innovative chemistry that surpasses ...

Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network

... Md. -- University of Kansas Specialized chemistry Center, University of Kansas, Lawrence, Kan. -- ... Albuquerque, N.M. -- Vanderbilt Specialized chemistry Center for Accelerated Probe Development, ... knowledge and wider understanding of probe chemistry will accelerate the development of new ...

Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences

... at the Gordon Research Conference on Medicinal chemistry this week at Colby Sawyer College, New London, ... ribosomal subunit with data-driven computational chemistry tools allows for a fresh look at ... process utilizing structural, computational and chemistry approaches; radezolid has distinct physical ...

Albemarle Optimizes Smallpox Drug Candidate for SIGA

... Fine chemistry Services unit demonstrates pilot production for ... Clary, Albemarle Division Vice President of Fine chemistry Services. "Our ability to support our customers' ... underlines our proven abilities to support the chemistry needs of developing pharmaceutical companies." ...

Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA

... chemical structures. Enanta has applied its chemistry approach to create promising product pipelines ... and development company that uses its novel chemistry approach and drug discovery capabilities to ... heart of Enanta is its commitment to innovative chemistry that surpasses ...

Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System

... Intelligent Lab System, an ultra-integrated chemistry analyzer. These tests are used by physicians to ... Intelligent Lab system. This ultra-integrated chemistry analyzer now offers one of the most comprehensive ... drugs-of-abuse testing, and routine and specialty chemistry testing. About Siemens Healthcare Diagnostics ...

Potent Hepatitis C Virus Inhibitors Show Efficacy and Potential for Once Daily Dosing in Preclinical Studies

... therapies and Enanta's core expertise in chemistry and drug discovery. The HCV NS 3/4A serine ... and development company that uses its novel chemistry approach and drug discovery capabilities to ... heart of Enanta is its commitment to innovative chemistry that surpasses ...

ACC Concerned Over Reporting of Biomonitoring Results

... resource issues around the globe. The American chemistry Council (ACC) supports efforts like this ... and man made. The fact is our bodies are chemistry in action. Everything we eat, breath, drink, or ... The American chemistry Council (ACC) represents the leading ...

One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials

... -- For more than 10 years, Mark Wentland, professor of chemistry and chemical biology at Rensselaer Polytechnic Institute , led a ... graduate and postdoctoral students in Rensselaer's Department of chemistry and Chemical Biology, along with Jean Bidlack, professor of pharmacology ...

Biotica Strikes Significant Collaboration Deal With GlaxoSmithKline

... compounds that are not readily accessible via conventional medicinal chemistry approaches. GSK will apply its expertise in macrolide drug discovery to ... derivatives that are either difficult or impossible to make by medicinal chemistry methods. For additional information visit http://www.biotica.com ...

WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System

... PCR platform. This innovative system, combined with next-generation chemistry and optimized assays being developed by WaferGen, promises to deliver ... (PCR) platform. This innovative system, combined with next-generation chemistry and optimized assays being developed by WaferGen, promises to deliver ...

Cytopia Scientific Presentations on JAK2 Inhibitor Program

... for a "best in class" inhibitor. Cytopia is a world leader in JAK2 kinase chemistry and holds a broad range of JAK2 related patents. The main focus of the ... of JAK2 inhibitors through an integrated computational and medicinal chemistry platform. Cytopia is developing a suite of JAK2 inhibitors for ...

Wild Blueberries Take Top Spot in New Antioxidant Research Study

... Journal of Agricultural and Food Chemistry (Journal Agricultural and Food chemistry 56 (18): 8418-8426, 2008) shows that Wild Blueberries have the highest ... assay is the first movement in the antioxidant field away from test tube chemistry assays and toward cell-based antioxidant activity assay. The recently ...

Cytopia Appoints Study Chairman for JAK2 Clinical Trial

... a "best in class" inhibitor. Cytopia is a world leader in JAK2 kinase chemistry and holds a broad range of JAK2 related patents. The main area of focus ... of JAK2 inhibitors through an integrated computational and medicinal chemistry platform. Cytopia is developing a suite of JAK2 inhibitors for ...

Low Acid Coffee Backed By Scientific Research

... March 27 /PRNewswire/ -- Puroast(R) Low Acid Coffee has conducted both chemistry and consumer research to confirm its claims that its great tasting, ... it uses a natural process that helps ensure the full-bodied taste. Prior chemistry research at University of California, Davis found Puroast(R) to have less ...

Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials

... development," said David Clary, Albemarle Division Vice President of Fine chemistry Services. "Our relationship with Anthera further demonstrates our proven abilities to support the chemistry and cGMP needs of emerging pharmaceutical companies." "This agreement ...

Pharmacopeia Announces Third Quarter 2007 Financial Results

... SARM program license, Pharmacopeia will apply a portion of its medicinal chemistry resources to an unrelated BMS discovery program for up to three years. ... quarter of 2007. This charge relates to the estimated fair value of the chemistry resources the company is to provide to BMS. In addition the company will ...

deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke

... of glaucoma; and deCODE BreastCancer, for the common forms of breast cancer. Its lead therapeutic programs, which leverage the company's expertise in chemistry and structural biology, include DG041, an antiplatelet compound being developed for the prevention of arterial thrombosis; DG051 and DG031, compounds ...

FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)

... companies in North America. These operating companies include: Eisai Research Institute of Boston, Inc., a discovery operation with strong organic chemistry capabilities; Morphotek, Inc., a biopharmaceutical company specializing in the development of therapeutic monoclonal antibodies; Eisai Medical ...

Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value

... companies in North America. These operating companies include: Eisai Research Institute of Boston, Inc., a discovery operation with strong organic chemistry capabilities; Morphotek, Inc., a biopharmaceutical company specializing in the development of therapeutic monoclonal antibodies; Eisai Medical ...

Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia

... Science Partners, SV Life Sciences and Novo A/S. Vantia Therapeutics is situated on Southampton Science Park, UK, where it occupies 10,000 sq ft of chemistry and biology facilities. For further information, please go to http://www.vantiatherapeutics.com . About nocturia Nocturia (defined as ...

Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies

... reduce the time and cost of drug development by integrating clinical pharmacology AME study conduct and data management services with bioanalytical chemistry and drug metabolism," said Robert Kochan, PhD, clinical pharmacology, Covance. "Our integrated service capabilities developed by our team of experts ...

Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System

... of six-color detection, with the potential for up to 60 different targets per sample. "This program will be primarily driven by our special chemistry capability which, along with software development, is expected to allow for completion of the program with no hardware modifications," said John ...

Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections

... there were no study discontinuations due to adverse events. Laboratory results showed no significant shifts from baseline in hematology or chemistry parameters, including platelets or liver enzymes. "The efficacy and safety of torezolid in this trial demonstrate its potential for the rapid ...

Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data

... advance warning of the future course of H1N1," noted Samuel Bogoch MD PhD, chairman and founder of Replikins Ltd. "Our understanding of the protein chemistry of rapid replication enables us to develop synthetic vaccines specifically tailored to destroy or restrict replication of the targeted virus strains ...

Lack of Food Variety Puts Kids With Autism at Risk for Poor Nutrition

... is also under design to give essential omega-3 fatty acids, such as docosahexanonic acid, to children with autism to see what impact it has on brain chemistry and/or the disorder. Increasing foods rich in omega-3 fatty acids in the diets of autistic children has been suggested by some researchers as ...

New Imaging Analysis Predicts Brain Tumor Survival

... approach that we can use to quantify treatment intervention in patients," says study author Brian Ross, Ph.D., professor of radiology and biological chemistry at the U-M Medical School and co-director of the Molecular Imaging Program at the U-M Comprehensive Cancer Center. The researchers looked at 44 ...

Major Restless Legs Study Completes Enrollment With Support From MediciGlobal

... and CEO Liz Moench notes: "This is achievable when clinical trial sites are engaged and motivated to meet timelines." She adds, "We had great team chemistry with the study sponsor -- a major Pharma company -- and clinical trial sites were highly enthusiastic about the recruitment program. They were ...

Vantia Therapeutics' Pipeline Continues to Mature

... Science Partners, SV Life Sciences and Novo A/S. Vantia Therapeutics is situated on Southampton Science Park, UK, where it occupies 10,000 sq ft of chemistry and biology facilities. For further information, please go to http://www.vantiatherapeutics.com . About nocturia: Nocturia (defined as ...

Avineuro Pharmaceuticals, Inc. Announces Beginning of Phase I Clinical Studies of AVN-211, Potent Small Molecule for Treatment of Schizophrenia.

... for unmet medical needs in neurology and psychiatry. Avineuro emphasizes a rational approach to drug discovery that combines modern medicinal chemistry with streamlined pre-clinical and clinical development studies, thus allowing a fast transition to proof-of-concept product candidates. ...

Quark Pharmaceuticals Presents at Asia TIDES Conference

... development platform that spans therapeutic target identification to drug development. Quark's RNAi technology includes novel siRNA structures and chemistry providing Quark with freedom to operate in the siRNA intellectual property arena, as well as the ability for non-invasive delivery of siRNA to other ...

Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor

... in whom the virus can be eradicated. About Enanta Enanta Pharmaceuticals is a research and development company that uses its novel chemistry approach and drug discovery capabilities to create best-in- class small molecule drugs in the anti-infective field. Enanta is developing novel ...

Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function

... development platform that spans therapeutic target identification to drug development. Quark's RNAi technology includes novel siRNA structures and chemistry providing Quark with freedom to operate in the siRNA intellectual property arena, as well as the ability for non-invasive delivery of siRNA to other ...

Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention

... novel agents in development and address the hospital, specialty, and chronic care markets. The Company's earlier-stage programs leverage Portola's chemistry capability to develop specific Syk and JAK inhibitors to treat cancer and inflammatory diseases. The company also has a novel FXa inhibitor antidote ...